Enzyme replacement in grafted nerve of twitcher mouse

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• The twitcher mouse is a recognized model for human globoid-cell leukodystrophy.
• This condition involves progressive demyelination in peripheral nerves, leading to neurological deficits.
• Krabbe-type inclusions are observed in macrophages and Schwann cells in affected mice.

Purpose of the Study:

• To investigate the potential for in vivo enzyme replacement therapy in the twitcher mouse model.
• To determine if morphological improvements in grafted nerves correlate with increased galactosylceramidase activity.
• To assess the long-term effects of nerve transplantation on globoid-cell leukodystrophy pathology.

Main Methods:

• Peripheral nerves from twitcher mice were transplanted into normal host mice.
• Nerve grafts were analyzed morphologically at various time points post-transplantation.
• Galactosylceramidase enzyme activity was measured in grafted sciatic nerves.
• Host Schwann cell migration and other host tissue contributions were investigated.

Main Results:

• Transplanted twitcher nerves initially showed globoid-cell leukodystrophy characteristics.
• After longer periods, grafts exhibited significant morphological improvement with reduced demyelination and fewer globoid cells.
• Galactosylceramidase activity in grafted nerves increased over time, reaching levels comparable to host nerves.
• Host Schwann cell migration was excluded as the sole cause of enzyme activity increase.

Conclusions:

• Nerve transplantation in twitcher mice leads to long-term in vivo enzyme replacement and pathological improvement.
• This study demonstrates the potential of gene therapy or cell-based therapies for treating genetic sphingolipidoses.
• The twitcher mouse model offers a valuable platform for studying therapeutic strategies for demyelinating diseases.